Cannabinoids
Yield Growth Clears Final Hurdle to Market Six New Products in Oregon
The cannabis industry is projected to reach $66.3 billion by 2025, according to Grand View Research, representing a blistering 23.9% compound annual growth rate. While medical and adult-use cannabis capture the headlines, cannabinoid-infused topicals, tinctures and capsules could become some of the fastest growing subsets of the market. Investors may want to take a […]
TORONTO Ms. Mojela to speak at Global Cannabis Partnership Launch in House of Commons Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that the Deputy Prime Minister of Lesotho, Mr. Monyane Moleleki will be joining CEO of Halo Labs Kiran Sidhu and Chairman of Bophelo Bioscience […]
Expected to Become First Ever African Business Woman to Chair a Publicly Traded Cannabis Company Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that upon closing of the previously announced acquisition of Bophelo Bioscience & Wellness (Pty) Ltd. (“Bophelo”) (the “Transaction”), the Company intends to appoint […]
Exclusive Interview with Wildflower Brands CEO: Health and Wellness Cannabis Products
Wildflower Brands (CSE: SUN, OTC: WLDFF) is a Vancouver-based company developing and designing brands that focus on plant-based health and wellness products. All of the company’s brands work in synergy toward becoming a global wellness leader. Wildflower distributes products across North America through the regulated cannabis markets as well as through nutraceutical channels, and the […]
Cannabis Supply Chain Management Expert: ManifestSeven
On March 28, 2019, trading of shares of P&P Ventures was halted as the company prepared to merge with ManifestSeven, change its name and ticker, and jump to the Canadian Securities Exchange. The new company is ManifestSeven Holdings, with a proposed ticker of MSVN in a going-public transaction that is receiving good support as measured […]
Zenabis Chief Growing Officer Outlines Potential in Exclusive Interview
Canada’s cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte, driven by the legalization of medical and adult-use cannabis. With concentrates and edibles anticipated later this year, licensed producers could reach new consumers that aren’t interested in smoking cannabis. Investors may want to take a closer look […]
Nabis™ Expands National Footprint with California Acquisition
There are many multi-state operators seeking a slice of the $14.5 billion U.S. cannabis industry, but few have the ambition and expertise of Nabis Holdings Inc. (CSE: NAB) (OTC: INNPF) (FRA: 7IP). Staying true to its name, meaning ‘repeat performance’ or ‘encore’, the co-founders behind MPX Bioceuticals Corp. (CSE: MPX), which was purchased by iAnthus […]
Betting Big on the New Age of Synthetic Cannabinoids
In the U.S. and globally, there is an explosion in demand for cannabinoids, naturally occurring components of the cannabis plant, for medical research purposes. The overarching problem, however, is that the natural extraction technologies that dominate the field today are chock full of issues, including high costs and potential for contamination. While the bias still […]
7 Minutes with Matt Willer and a Little Cannabis Alliteration
Marcus Lemonis, the iconic entrepreneurial Profit, is famously known for building successful businesses under the mantra of “people, process and product.” If there is a company employing the “3 P’s” recipe in the cannabis space, it’s STWC Holdings Inc. (OTCQB: STWC), or Strainwise Consulting as it is often called, a company steeped with experience […]
Halo Labs to Expand Globally and Acquire Bophelo Bioscience
Cannabis Industry in Lesotho, Africa to Become Gateway to EU Cannabis Markets Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that it has entered into a non-binding letter of intent (LOI) for the proposed acquisition of Bophelo Bioscience & Wellness (Pty) Ltd (“Bophelo”) (the “Transaction”). The […]
FSD Pharma Continues to Add Expert Advisors Amid Buildout of Massive Facility
FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) has been focused on building out its board of directors and advisory board since becoming a full Canadian licensed producer earlier this year. After receiving its cultivation license in 2017, the company began work on a massive cultivation facility that could house nearly four million sq. ft. on […]
Freshly Public, This Company is Building a Global Cannabis Footprint
Jushi Holdings Inc. (NEO: JUSH) made its public debut on Monday, June 10th. The Boca Raton-based company has assembled a highly skilled and diversified team that is moving with a purpose, building a global footprint via organic and inorganic growth to capitalize on booming demand for cannabidiol, or CBD, in North America and abroad. According […]
FinCanna’s QVI Looks to Become California’s Premier Contract Manufacturer
California’s cannabis industry is projected to reach $7.7 billion in revenue by 2021, according to *BDS Analytics and Arcview Group, driven by the legalization of adult-use cannabis. Within this market, manufactured products, edibles, and concentrates have outpaced cannabis flower to become the *fastest growing segment of the market. Concentrates can be incorporated into many different […]
Cannabis Pioneer Strainwise Takes an Innovative Approach to the Industry
STWC Holdings Inc. (OTCQB: STWC), better known as Strainwise®, was founded by two cannabis industry pioneers that aim to transform their consulting practice into a national cannabis enterprise. Co-founder/CEO Erin Phillips acquired the first recreational cannabis license in the world for one of her clients, The Annie’s: A STRAINWISE® Branded Dispensary in Central City, Colorado. […]
How Celebrities & Politicians Help Build Cannabis Brands
There’s no doubt that celebrities can have a significant influence on a brand, particularly when it comes to Gen Z and Millennial demographics. At the same time, politicians can lend an air of credibility and provide valuable insights into the regulatory future of a market. These attributes have made them invaluable to cannabis companies that […]
As a new industry, the next few months will be pivotal for the development of the cannabis market. With laws changing every month in jurisdictions around the globe, the room for growth is huge as the industry continues to mature. A recent study by Statista showed that in 2018, the global sales of hemp amounted […]
Isracann Raises C$10.1 Million in Bid to Supply European Market with Israeli Cannabis
The global cannabis industry is projected to be worth nearly $150 billion by 2025, according to Grand View Research, driven by the liberalization of cannabis laws around the world. Many investors have been focused on North America given Canada’s move to legalize recreational use and the growing number of states doing the same. However, Europe’s […]
Distribution, Brands, and Revenue Growth are Key for Emerging Cannabis Companies
As the legal cannabis market matures across North America, the story is slowly turning from potential to reality. Companies are being examined more closely than ever to gauge which ones have staying power, which ones are executing on long-heralded plans, and which ones are actually creating revenue from whatever it is they are selling. There […]
Halo Labs Revenue Triples After Expansion into California & Nevada
Halo Labs Inc. (NEO: HALO) (OTCQX: AGEEF) revenue tripled to more than $8.7 million after launching cannabis oil and concentrate operations in California and Nevada. The company’s California operations generated $5,324,396 in revenue; it’s Nevada-based business generated $514,365 in revenue; and its existing Oregon operations reported a 32.8% increase in revenue to $2,168,975 for the […]
FSD Pharma CEO Lays Out Roadmap in Exclusive Interview with CFN Media
FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) is a licensed producer focused on building out a 3.9 million sq. ft. indoor hydroponic facility near Toronto capable of producing 400,000 kilograms of dried cannabis per year. With a newly acquired sales license and 25,000 sq. ft. already in production, the company is on the cusp of […]
Pascal Biosciences Announces Formation of Clinical Advisory Board
Preeminent Neuro-Oncology Experts to Guide PAS-403 Development Efforts VANCOUVER, British Columbia and SEATTLE, May 08, 2019 (GLOBE NEWSWIRE) — Pascal Biosciences Inc. (TSX.V:PAS)(“Pascal” or the “Company”), a drug discovery and development company, today announced it has formed a clinical advisory board (“CAB”) of preeminent neuro-oncology experts to guide its PAS-403 therapeutic program. PAS-403 is Pascal’s clinical […]
FSD Pharma Doubles Down on Endocannabinoid-based Pain Management
Chronic pain is a widespread condition affecting about one-third of the American population and billions of other people around the world. Despite their widely known dangers, opioids quickly became one of the most prescribed and profitable classes of drugs in the world. The ensuing opioid crisis has made overdoses a leading cause of non-disease deaths […]
Why Cannabis Genetics Matter & How to Invest in Innovations
Cannabis cultivators and budtenders love to talk about genetics. While everyone has an opinion on the effects of specific strains, recent research suggests that the effects of cannabis aren’t necessarily consistent with strains, and the generally accepted classifications of indiva, sativa and hybrid varieties may be flawed. Very few companies are investing in truly understanding […]
Yield Growth’s New Subsidiary, Wright & Well, Positioned to Disrupt the Wellness Market
The Yield Growth Corp. (CSE: BOSS) has proven itself a serious contender in the legal cannabis market, and will be a particularly exciting candidate to follow as the industry continues to evolve from just flower to other cannabis based products. Yield Growth’s flagship brand, Urban Juve, produces exceptional wellness and beauty items, rooted in ancient […]
Halo Expands Branded Products & Launches Hemp CBD Products
The cannabis industry is projected to reach $146.4 billion by 2025, according to Grand View Research, driven by the legalization of recreational cannabis across a growing number of states and countries. While there are many different opportunities in the space, there are only a handful of companies that have proven their ability to generate significant […]
TransCanna Acquires Massive Vertically Integrated Cannabis Facility in California
California’s cannabis industry is projected to generate more than $6.5 billion in annual revenue by 2020, according to New Frontier Data and Arcview Market Research, which represents a 23.1% compound annual growth rate. Many companies are racing to build their production footprint, introduce new brands, expand distribution, and open new dispensaries, but few have reached […]
The Spotlight Shines on CFN Media’s Clients at The O’Cannabiz Awards
The O’Cannabiz Conference and Expo is coming to Toronto on April 25, bringing together thousands of cannabis experts and brands. Ricki Lake, Montel Williams, Jacqui Childs, Henry Rollins and other famous personalities will be featured speakers at the High Canada Magazine #1 Cannabis Event in Canada, while investors can learn about topics ranging from policy […]
Supreme Cannabis Continues To Achieve Milestones in 2019
The Canadian cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte, driven by the legalization of adult-use cannabis last year and the upcoming legalization of edibles later this year. While many companies have focused on scaling up their production capacity at any cost, investors may want to shift focus […]
Helix Sees Triple-Digit Growth as It Looks to Expand in California
The global cannabis industry is projected to surpass $146.4 billion in revenue by 2025, according to Grand View Research, with the U.S. fueling much of that growth. While many investors are focused on cultivation and extraction, these businesses involve a high capital expenditure and could end up producing a commoditized product. Investors may want to […]
Why Branding Matters in the Cannabis Industry
The global cannabis industry is projected to reach $146.4 billion by 2025, according to Grand View Research, representing a blistering 34.6 percent compound annual growth rate. While the industry is known for strain names, like OG Kush and Girl Scout Cookies, there aren’t established marquee brands like those found in tobacco or pharmaceutical industries—which has […]
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Matthew Nordgren is an ambitious executive, dedicated philanthropist, and accomplished athlete who brings a unique passion to creating strategic alliances. He has breadth and depth of experience in finance, corporate development, and capital sourcing, as well as in building highly motivated teams of skilled professionals. In 2005, Mr. Nordgren received his education at the University […]
In addition to his role as Founder and CEO at MAZAKALI, Sumit is a consultant to The Arcview Group and the Managing Partner of Emerald Ventures. A frequent speaker at investment seminars, Sumit acts as a mentor to Arcview and Canopy companies and serves on the Canopy Investment committee as well as the NCIA Finance […]
MichiCann Medical Inc. owns or controls 11 medical cannabis dispensaries in Michigan and is in the final stages to acquire another 11 shops, as well as three indoor cultivation facilities in the state.
JWC is a Licensed Producer under the ACMPR with the goal of helping patients by providing clean, consistent medical cannabis products.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
